Source: International Congress 2015 – Interstitial lung diseases I
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Makiko Yomota (Tokyo, Japan), Makiko Yomota, Tatsuru Okamura, Yusuke Ohkuma, Yukio Hosomi, Hirotoshi Horio, Kazuteri Ohashi, Tsunekazu Hishima. Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation. Eur Respir J 2015; 46: Suppl. 59, 813

Member's Comments

No comment yet.

Related content which might interest you: Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Pulmonary function and respiratory complications in hematopoietic cell transplant Source: International Congress 2016 – Quality and quantity in lung function Year: 2016 Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Lung transplantation for pulmonary fibrosis Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Pulmonary alveolar proteinosis due to monocytopenia: Lung transplant or haematopoeitic stem cell transplant? Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Lung transplantation in systemic sclerosis: Experience in a spanish center Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease Year: 2016 Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Lung transplantation in idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 The role of CCR2+CD4+T cells in lung fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Noninfectious pulmonary complications of haematopoietic stem cell transplantation Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019 Year: 2020 Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Lung transplantation in silicosis, still rare Source: Virtual Congress 2020 – Occupational lung diseases Year: 2020 Noninfectious pulmonary complications after organ transplantation Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=202 Year: 2005 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016